EVARREST: payments to doctors
Payments that named EVARREST as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.4M
- Providers
- 3,766
- Transactions
- 5,884
- Average per transaction
- $240
The per-transaction average — $240 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 3,766 providers the average total is $376, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Johnson & Johnson | $777,627 | 55.0% |
| Medical Device Business Services, Inc. | $637,459 | 45.0% |